• Explore /
  • Poster
  • / Hypofractionated dose painting IMRT using 20 fractions for intermediate to high risk localised prostate cancer: Two-year outcome data (BIOPROP20, NCT02125175).

Hypofractionated dose painting IMRT using 20 fractions for intermediate to high risk localised prostate cancer: Two-year outcome data (BIOPROP20, NCT02125175).

Abstract Poster

Authors

null

Isabel Syndikus

Clatterbridge Cancer Centre, Wirral, United Kingdom

Isabel Syndikus , Joachim Kwok-Chiu Chan , Thelma Rowntree , Laura Howard , John Staffurth

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Clinical Trial Registration Number

NCT02125175

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 59)

DOI

10.1200/JCO.2019.37.7_suppl.59

Abstract #

59

Poster Bd #

D5

Abstract Disclosures

Similar Posters

First Author: Joan Carles

First Author: Sagar A. Patel

First Author: Jonathan W. Lischalk

First Author: Sean Matthew McBride